News

Entocort (budesonide) is currently approved in more than 40 countries to treat Crohn’s disease (CD) and ulcerative colitis (UC). The US rights of Entocort will remain with AstraZeneca,

As a result, Immune will transfer to Endo its previously licensed patents related to the use of topical lidocaine in acute and chronic back pain and Endo will

The amount of payment was not disclosed. The payment was triggered by the achievement of positive in vivo proof of concept data and progression of the Anticalin drug

Entresto (previously known as LCZ696) will be provided on prescription for patients whose condition is classified NYHA class II-IV and indicated to reduce the risk of cardiovascular death

Earlier in March, the company received approval of an abbreviated new drug application (ANDA) for the product from the US Food and Drug Administration (FDA) The company’s product

As part of the deal, both the firms will jointly work to develop an adjuvanted non-alum based rPA vaccine. The deal provides PharmAthene exclusive worldwide rights to use

As part of its collaboration agreement with the French firm, Cellectis is eligible for an undisclosed payment. Signed in February 2014, the collaboration is focused on research, development

Each year, manufacturers of influenza vaccine must receive approval from the FDA for changes they make to their vaccines so that the vaccines protect against the new strains

Arrowhead’s ARC-AAT is being investigated for the treatment of liver disease associated with the rare genetic disorder alpha-1 antitrypsin deficiency (AATD). The Phase I trial is currently enrolling